What is a stock summary page? Click here for an overview.
Business Description
Vitrolife AB
ISIN : US92852Y1010
Share Class Description:
VTRLY: ADRCompare
Compare
Traded in other countries / regions
VITR.Sweden0YAY.UKVTFN.GermanyVTRLY.USA IPO Date
2016-04-11Description
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receiveĀ support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.54 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | 2.67 | |||||
| Interest Coverage | 7.12 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.78 | |||||
| Beneish M-Score | -2.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22 | |||||
| 3-Year EBITDA Growth Rate | 4.6 | |||||
| 3-Year EPS without NRI Growth Rate | 8.5 | |||||
| 3-Year FCF Growth Rate | 33.7 | |||||
| 3-Year Book Growth Rate | -3.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 19.1 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 7.85 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 1.85 | |||||
| 9-Day RSI | 10.37 | |||||
| 14-Day RSI | 16.59 | |||||
| 3-1 Month Momentum % | -3.98 | |||||
| 6-1 Month Momentum % | -28 | |||||
| 12-1 Month Momentum % | 35.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.34 | |||||
| Quick Ratio | 2.74 | |||||
| Cash Ratio | 1.61 | |||||
| Days Inventory | 99.59 | |||||
| Days Sales Outstanding | 59.65 | |||||
| Days Payable | 44.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.51 | |||||
| Dividend Payout Ratio | 0.27 | |||||
| 3-Year Dividend Growth Rate | 7.7 | |||||
| Forward Dividend Yield % | 0.55 | |||||
| 5-Year Yield-on-Cost % | 0.51 | |||||
| Shareholder Yield % | 1.04 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.29 | |||||
| Operating Margin % | 21.7 | |||||
| Net Margin % | 14.22 | |||||
| FCF Margin % | 24.06 | |||||
| ROE % | 3.9 | |||||
| ROA % | 3.04 | |||||
| ROIC % | 3.8 | |||||
| 3-Year ROIIC % | -10.28 | |||||
| ROC (Joel Greenblatt) % | 84.81 | |||||
| ROCE % | 4.82 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 42.65 | |||||
| Forward PE Ratio | 42.96 | |||||
| PE Ratio without NRI | 42.65 | |||||
| Shiller PE Ratio | 1671.16 | |||||
| Price-to-Owner-Earnings | 58.03 | |||||
| PS Ratio | 6.05 | |||||
| PB Ratio | 1.6 | |||||
| Price-to-Free-Cash-Flow | 25.11 | |||||
| Price-to-Operating-Cash-Flow | 24.06 | |||||
| EV-to-EBIT | 29.11 | |||||
| EV-to-EBITDA | 29.11 | |||||
| EV-to-Revenue | 6.32 | |||||
| EV-to-FCF | 26.2 | |||||
| Price-to-GF-Value | 0.7 | |||||
| Price-to-Projected-FCF | 1.15 | |||||
| Price-to-Median-PS-Value | 0.47 | |||||
| Earnings Yield (Greenblatt) % | 3.44 | |||||
| FCF Yield % | 3.98 | |||||
| Forward Rate of Return (Yacktman) % | 5.96 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VTRLY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
Vitrolife AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 342.568 | ||
| EPS (TTM) ($) | 0.359 | ||
| Beta | 0.76 | ||
| 3-Year Sharpe Ratio | -0.08 | ||
| 3-Year Sortino Ratio | -0.11 | ||
| Volatility % | 63.79 | ||
| 14-Day RSI | 16.59 | ||
| 14-Day ATR ($) | 0.00267 | ||
| 20-Day SMA ($) | 18 | ||
| 12-1 Month Momentum % | 35.34 | ||
| 52-Week Range ($) | 13.3 - 25 | ||
| Shares Outstanding (Mil) | 135.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vitrolife AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vitrolife AB Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vitrolife AB Frequently Asked Questions
What is Vitrolife AB(VTRLY)'s stock price today?
The current price of VTRLY is $18.00. The 52 week high of VTRLY is $25.00 and 52 week low is $13.30.
When is next earnings date of Vitrolife AB(VTRLY)?
The next earnings date of Vitrolife AB(VTRLY) is 2025-04-16.
Does Vitrolife AB(VTRLY) pay dividends? If so, how much?
TheĀ Dividend Yield % Ā of Vitrolife AB(VTRLY) is 0.51% (As of Today), HighestĀ Dividend Payout RatioĀ of Vitrolife AB(VTRLY) was 0.27. The lowest was 0.19. And the median was 0.26. The Ā Forward Dividend Yield % of Vitrolife AB(VTRLY) is 0.55%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers